| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.2B | $17.5B | $18.8B | $22.3B | $18.4B | $2.6B | $2.4B | $2.9B |
| Cost of Revenue | $15.8B | $14.7B | $14.7B | $16.1B | $13.0B | $8.2B | $8.9B | $9.5B |
| Gross Profit | $2.4B | $2.8B | $4.0B | $6.1B | $5.4B | $0.4B | $0.3B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.8B | $0.7B | $0.6B | — | — | — | — | $0.6B |
| Operating Income | $1.5B | $1.9B | $3.2B | $5.1B | $4.3B | $0.3B | $0.2B | $0.4B |
| Net Income | $1.2B | $1.5B | $2.5B | $3.9B | $3.2B | $0.2B | $0.1B | $0.3B |
| EPS (Basic) | $8.02 | $9.89 | $14.72 | $21.06 | $15.67 | $0.89 | $0.56 | $1.18 |
| EPS (Diluted) | $7.99 | $9.84 | $14.64 | $20.92 | $15.56 | $0.89 | $0.56 | $1.17 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.4B | $14.9B | $14.9B | $14.2B | $12.5B | $9.3B | $8.3B | $7.7B |
| Current Assets | $6.5B | $5.4B | $6.8B | $7.6B | $6.9B | $4.3B | $4.3B | $4.0B |
| Cash & Equivalents | $0.8B | $0.6B | $1.4B | $1.6B | $1.2B | $1.4B | $1.4B | $0.8B |
| Total Liabilities | $7.5B | $6.0B | $6.1B | $6.1B | $6.2B | $4.9B | $4.2B | $3.8B |
| Current Liabilities | $2.1B | $2.2B | $2.3B | $2.0B | $2.2B | $1.3B | $1.0B | $1.0B |
| Stockholders' Equity | $9.0B | $8.9B | $8.9B | $8.1B | $6.3B | $4.3B | $4.1B | $3.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.8B | $3.5B | $4.5B | $2.2B | $1.0B | $1.4B | $1.4B |
| Investing Cash Flow | $-1.0B | $-1.3B | $-2.0B | $-1.9B | $-1.0B | $-1.0B | $-0.6B | $-0.9B |
| Capital Expenditures | $0.9B | $1.9B | $1.7B | $0.9B | $1.0B | $1.2B | $0.5B | $0.2B |
| Financing Cash Flow | $-0.3B | $-1.4B | $-1.8B | $-2.2B | $-1.3B | $-0.0B | $-0.3B | $-0.7B |